Indian Gliclazide Exporters: Complete Supplier Ranking with Market Share — 238 Manufacturers (2026) — TransData Nexus

Q: Who is the largest gliclazide supplier from India?

MYLAN LABORATORIES LIMITED is the largest gliclazide exporter from India with a 60.4% market share and export value of $181.6M.

Q: How many gliclazide suppliers are there in India?

There are 238 active gliclazide exporters in India, collectively shipping $300.8M worth of gliclazide across 3,830 shipments according to Indian Customs (DGFT) records.

Q: What is the market share of top gliclazide suppliers from India?

The top 5 gliclazide suppliers from India — MYLAN LABORATORIES LIMITED, PANACEA BIOTEC PHARMA LIMITED, SUN PHARMACEUTICAL INDUSTRIES LIMITED, MICRO LABS LIMITED, IPCA LABORATORIES LIMITED — together control 83.0% of total gliclazide export value from India.

Suresh Sormare

Gliclazide

India Pharmaceutical Trade Intelligence

$300.8M238 Suppliers109 CountriesHS 30049099

ExportsIndia → HUNGARY29.3%India → NETHERLANDS29.2%

ImportsUNITED KINGDOM → India$1.0M BULGARIA → India$261.6K

#1 Supplier: MYLAN LABORATORIES #1 Buyer: MYLAN HUNGARY

Gliclazide Suppliers from India (2026) — 238 Exporters, $300.8M Market | TransData Nexus | TransData Nexus

Who Exports Gliclazide from India — 238 Suppliers Behind a $300.8M Market

India's gliclazide export market is supplied by 238 active exporters who collectively shipped $300.8M across 3,830 shipments. MYLAN LABORATORIES LIMITED leads with a 60.4% market share, followed by PANACEA BIOTEC PHARMA LIMITED and SUN PHARMACEUTICAL INDUSTRIES LIMITED. The top 5 suppliers together control 83.0% of total export value, reflecting a concentrated market structure.

Source: Indian Customs (DGFT)·Published March 2026

India's Top Gliclazide Suppliers & Exporters — 238 manufacturers, $300.8M export market, top destinations and formulations — Gliclazide supplier data — 238 exporters · $300.8M market · 3,830 shipmentsTransData Nexus · Indian Customs Data

Top Gliclazide Exporters from India — Ranked by Export Value

MYLAN LABORATORIES LIMITED is the leading gliclazide exporter from India, holding a 60.4% share of the $300.8M market across 3,830 shipments from 238 exporters. The top 5 suppliers — MYLAN LABORATORIES LIMITED, PANACEA BIOTEC PHARMA LIMITED, SUN PHARMACEUTICAL INDUSTRIES LIMITED, MICRO LABS LIMITED, IPCA LABORATORIES LIMITED — collectively control 83.0% of total export value, indicating a highly concentrated market. Individual shares are: MYLAN LABORATORIES LIMITED (60.4%), PANACEA BIOTEC PHARMA LIMITED (12.6%), SUN PHARMACEUTICAL INDUSTRIES LIMITED (5.0%), MICRO LABS LIMITED (2.5%), IPCA LABORATORIES LIMITED (2.4%).

Top Gliclazide Exporters from India

Ranked by export value · 238 active suppliers · Indian Customs (DGFT) data

Mar 2026

Top Gliclazide Exporters from India — Ranked by Export Value. 238 active suppliers with export value, shipments, countries and formulations data compiled from Indian Customs records by TransData Nexus.
#	Supplier & Formulations	Value	Ships.	Ctry.	Share
1

Gliclazide — Export Intelligence Video

Visual overview of India's gliclazide supplier landscape — top suppliers, destinations, pricing, and trade routes

This video covers India's gliclazide pharmaceutical supplier landscape — $300.8M in total trade, 238 verified manufacturers. Data sourced from Indian Customs (DGFT) shipment records.

Supplier Certification & Compliance Matrix

FDA, WHO-GMP, and EU GMP status for top Gliclazide exporters

Certification and compliance status for top Gliclazide suppliers from India
Supplier	US FDA	WHO-GMP	EU GMP	ANDAs	Notes
Micro Labs Limited	Not Listed	Yes, inspected Augus	Yes	Not verified	WHO-GMP inspections conducted in 2024 and 2025; EU GMP compliant.
Mylan Laboratories Limited	Not Listed	Yes, inspected April	Yes	Not verified	WHO-GMP inspection conducted in 2025; EU GMP compliant.
Sun Pharmaceutical Industries Limited	Not Listed	Not Listed	Yes	Not verified	EU GMP compliant.
Panacea Biotec Pharma Limited	Not Listed	Not Listed	Yes	Not verified	EU GMP compliant.
Unichem Laboratories	Not Listed	Not Listed	Yes	Not verified	EU GMP compliant.
Lincoln Pharmaceuticals	Not Listed	Not Listed	Yes	Not verified	EU GMP compliant.

TransData Nexus reviewed the regulatory standing of 6 leading Gliclazide exporters from India. 0 hold US FDA facility approvals, 2 maintain WHO-GMP certification, and 6 are EU GMP compliant. For regulated markets (US, EU, Australia), prioritise suppliers with active FDA or EU GMP approvals. For semi-regulated markets (Africa, ASEAN, Latin America), WHO-GMP certification is the minimum recommended standard.

Certification status compiled from publicly available regulatory databases including FDA Orange Book, WHO Prequalification database, and EMA GMP registry. Buyers should independently verify compliance status with the relevant regulatory authority before placing orders.

TransData Nexus Research · Mar 2026

Manufacturing Hub Analysis — Vendor Proximity

India's pharmaceutical clusters relevant to Gliclazide sourcing

1Hyderabad — Bulk Drug Capital

Hyderabad, often referred to as the "Bulk Drug Capital of India," is a major hub for the production of Active Pharmaceutical Ingredients (APIs). The city hosts over 800 pharmaceutical companies, including industry leaders such as Dr. Reddy’s Laboratories, Aurobindo Pharma, and Divi’s Laboratories. Hyderabad's Genome Valley, India's first biotech cluster, provides advanced R&D infrastructure and a skilled talent pool, making it a prime location for API manufacturing.

2Ahmedabad-Vadodara — Formulations Hub

The Ahmedabad-Vadodara corridor in Gujarat is renowned for its focus on pharmaceutical formulations. Gujarat contributes nearly 28% of India's pharmaceutical production and is home to major companies like Zydus Cadila, Intas Pharmaceuticals, and Torrent Pharmaceuticals. The region's robust infrastructure, including well-developed ports and transportation networks, supports efficient manufacturing and distribution of pharmaceutical products.

3Mumbai-Thane-Raigad — Export Gateway

The Mumbai-Thane-Raigad belt in Maharashtra serves as a critical export gateway for India's pharmaceutical industry. With 929 pharmaceutical units, Maharashtra is a significant contributor to the sector. The region's proximity to major ports facilitates seamless export operations, making it a strategic location for companies aiming to access international markets.

Recent M&A, Collaborations & Capacity Expansions

Industry developments among top Gliclazide exporters from India

January 2024

M&A

SUN PHARMACEUTICAL INDUSTRIES LIMITED — Sun Pharma acquires remaining stake in Taro Pharmaceuticals for $347.73 million

In January 2024, Sun Pharma entered into a definitive merger agreement to acquire the remaining stake in Taro Pharmaceuticals for $347.73 million. This acquisition aimed to consolidate Sun Pharma's position in the global pharmaceutical market. - IMPACT: The acquisition is expected to enhance Sun Pharma's production capabilities, potentially increasing Gliclazide exports.

Impact: The acquisition is expected to enhance Sun Pharma's production capabilities, potentially increasing Gliclazide exports.

TransData Nexus Industry Research · Regulatory filings and press releases · Mar 2026

Common Questions — Gliclazide Suppliers from India

Answers based on Indian Customs (DGFT) shipment records compiled by TransData Nexus

Q Which gliclazide supplier from India is the most reliable for bulk orders?

Based on shipment frequency and export consistency, MYLAN LABORATORIES LIMITED leads with 133 recorded shipments worth $181.6M. PANACEA BIOTEC PHARMA LIMITED (50 shipments) and SUN PHARMACEUTICAL INDUSTRIES LIMITED (470 shipments) are also established high-volume exporters.

Q How many gliclazide manufacturers are there in India?

India has 238 active gliclazide exporters with a combined export market of $300.8M across 3,830 shipments to 109 countries. The top 5 suppliers hold 83.0% of total export value.

Q What certifications should I verify?

Verify: WHO-GMP certification (most markets), US FDA approval (United States), EU GMP certificate (EU/EEA), and Free Sale Certificate from CDSCO. Always request a Certificate of Analysis (CoA) and Certificate of Origin (CoO).

Q What is the typical price range for gliclazide from India?

Average FOB unit price: $6.75 per unit, ranging from $0.00 to $749.73. Average shipment value: $78.5K.

Official References & Regulatory Resources

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Gliclazide

Gliclazide

Who Exports Gliclazide from India — 238 Suppliers Behind a $300.8M Market

Top Gliclazide Exporters from India — Ranked by Export Value

Top Gliclazide Exporters from India

Related Analysis

Need Details?

Gliclazide — Export Intelligence Video

Supplier Certification & Compliance Matrix

Manufacturing Hub Analysis — Vendor Proximity

1Hyderabad — Bulk Drug Capital

2Ahmedabad-Vadodara — Formulations Hub

3Mumbai-Thane-Raigad — Export Gateway

Recent M&A, Collaborations & Capacity Expansions

SUN PHARMACEUTICAL INDUSTRIES LIMITED — Sun Pharma acquires remaining stake in Taro Pharmaceuticals for $347.73 million

Common Questions — Gliclazide Suppliers from India

Q Which gliclazide supplier from India is the most reliable for bulk orders?

Q How many gliclazide manufacturers are there in India?

Q What certifications should I verify?

Q What is the typical price range for gliclazide from India?

Official References & Regulatory Resources

Research Methodology & Data Transparency

Suresh Sormare

Primary Data Source

4Baddi-Nalagarh — Tax Incentive Zone

5Sourcing Recommendations

Analysis Methodology